Resistin Serum Levels in Type 1 Diabetes Pre- and Post-Islet Transplantation

Metabolism: Clinical and Experimental

Volumn 53, Issue 4, 2004, Pages 403-404

  Shalev, Anath ^a,b,c   Patterson, Noelle B ^a   Hirshberg, Boaz ^a   Rother, Kristina I ^a   Harlan, David M ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACLIZUMAB; RAPAMYCIN; RESISTIN; TACROLIMUS;

ADIPOCYTE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET TRANSPLANTATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

EID: 1842427269     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2003.11.014     Document Type: Article

References (14)

1. Holcomb IN, Kabakoff RC, Chan B, et al: FIZZI, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19:4046-4055, 2000
2. Kim KH, Lee K, Moon YS, et al: A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 276:11252-11256, 2001
3. Steppan CM, Bailey ST, Bhat S, et al: The hormone resistin links obesity to diabetes. Nature 409:307-312, 2001
4. Hotamisligil GS: The irresistible biology of resistin. J Clin Invest 111:173-174, 2003
5. Rajala MW, Obici S, Scherer PE, et al: Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest 111:225-230, 2003
6. McTernan CL, McTernan PG, Harte AL, et al: Resistin, central obesity, and type 2 diabetes. Lancet 359:46-47, 2002
7. Smith SR, Bai F, Charbonneau C, et al: A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 52:1611-1618, 2003
8. Fehmann HC, Heyn J: Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls. Horm Metab Res 34:671-673, 2002
9. Kielstein JT, Becker B, Graf S, et al: Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. Am J Kidney Dis 42:62-66, 2003
10. Yannakoulia M, Yiannakouris N, Bluher S, et al: Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 88:1730-1736, 2003
11. Ryan EA, Lakey JR, Paty BW, et al: Successful islet transplantation: Continued insulin reserve provides long-term glycemic control. Diabetes 51:2148-2157, 2002
12. Hirshberg B, Rother KI, Digon BJ, et al: Benefits and risks of solitary islet transplantation for type 1 diabetes mellitus using steroid sparing immunosuppression: The NIH experience. Diabetes Care 26: 3288-3295, 2003
13. Legro RS, Finegood D, Dunaif A: A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83:2694-2698, 1998
14. Bergman RN: Lilly Lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 38: 1512-1527, 1989